🚀 UMC $1.7M Bullish ATM Call Bet — Whale Targets Foundry Recovery Through June

📅 May 5, 2026 | 🔥 Unusual Activity Detected

---

🎯 The Quick Take

Someone just dropped $1.7 million on a single block of UMC June 18 $14 calls — 15,000 contracts lifted at the ask at 13:59:42, at-the-money with spot sitting at $14.04, printing a Z-score of 108.45 against open interest of only 592. This is not a hedge. With vol/OI of 25x, this is an aggressive, standalone directional bet that United Microelectronics Corporation — Taiwan's second-largest pure-play foundry — will trade above $15.23 by June 18 expiration, a ~8% rally from current levels. The context makes the conviction intelligible: fresh off a 48% Q1 2026 EPS beat, an active share buyback through June 29, Singapore Phase 3 volume production ramping, and April mature-node price hikes of up to 10% just now flowing through ASPs. Someone who has done their homework on the semiconductor supply cycle is buying calls with 44 days to expiration, right at-the-money, when the stock is within cents of key gamma support at $14.00.

---

📊 Company Overview

United Microelectronics Corporation (NYSE: UMC) is Taiwan's second-largest pure-play semiconductor foundry and one of the world's premier manufacturers of mature and specialty-node chips, headquartered in Hsinchu, Taiwan. Founded in 1980 as Taiwan's first dedicated semiconductor company, UMC operates 12 fabs across Taiwan, Singapore, China (Xiamen, Suzhou via HeJian), and Japan (Mie prefecture), with strategic focus on 22nm/28nm specialty processes, 40nm and 65nm logic, and high-voltage/RF/embedded-flash technologies that power display drivers, image sensors, MCUs, IoT connectivity chips, automotive ICs, and power-management devices.

Unlike TSMC's leading-edge ambitions, UMC competes in the mature "trailing-edge" foundry segment alongside SMIC and Hua Hong, Taiwan's Vanguard (VIS) and Powerchip (PSMC), and increasingly Intel via the 12nm Arizona JV expected to reach tape-out in late 2026. Chinese state-subsidized capacity expansion has driven painful pricing pressure since late 2024, but April 2026 marks the first coordinated price hike cycle — up to 10% — from UMC, VIS, PSMC, and Nexchip, signaling a potential trough in the mature-node pricing collapse.

• Market Cap: ~$24.4B – $30.9B (range across April 2026 sources)
• Shares Outstanding: ~12.56B common shares
• Industry: Semiconductor Manufacturing / Pure-Play Foundry
• Spot Price on Trade Date: $14.04 (May 5, 2026)
• 52-Week Range: $6.56 – $12.68 (note: current price near or through 52-week high)
• 3-Month Performance: +90% off February 2026 lows ($6.80 area), driven by mature-node price-hike newsflow, Q1 beat, and buyback announcement
• Primary Business Drivers: 22/28nm specialty foundry revenue, mature-node pricing cycle normalization, Singapore fab expansion, Intel-Arizona partnership

---

💰 The Option Flow Breakdown

📊 What Just Happened — The Tape (May 5, 2026 @ 13:59:42)

This is a standalone BTO (Buy to Open) — a single-leg directional call purchase with no paired hedge or spread. The classifier confirms STANDALONE strategy role, meaning the buyer is not offsetting risk with a short leg. They are buying pure optionality.

🤓 What This Actually Means

• 🐋 BTO (Buy to Open): The trader paid $1.7M in premium to open a long call position on 15,000 contracts of the UMC June 18, 2026 $14 strike calls. Premium paid: approximately $1.23 per contract per share, or $11,333 per contract (100 shares each), $1.7M total. This gives the buyer the right — but not the obligation — to purchase UMC shares at $14.00 through June 18 expiration. Every dollar UMC rallies above the breakeven of $15.23 generates $1.5M in profit on this position (15,000 contracts × 100 shares × $1.00).

• 🎯 ATM Positioning — Why This Matters: With spot at $14.04, the $14 strike is essentially at-the-money (ATM). ATM options carry the highest gamma of any strike — the position's delta is currently near 0.50, meaning every $1 move in UMC stock translates to approximately $750,000 in P&L change (15,000 × 100 × $0.50). The buyer is maximizing sensitivity to near-term price movement.

• 🔥 Extremely Unusual Signal — Z-Score 108.45: A Z-score of 108.45 means this volume is 108 standard deviations above the expected daily activity for this contract. Against an open interest of only 592 contracts, 15,000 contracts represent 25.34x the existing OI — this trade essentially multiplied UMC's June $14 call open interest by 26x in a single print. This is not a retail trader making a casual directional bet. This is concentrated institutional conviction arriving in size.

• 📈 Max profit is uncapped: Unlike a spread, this long call has theoretically unlimited upside. There is no short leg capping the profit. Every dollar above $15.23 at expiration generates $1.5M. If UMC re-rates to $17 or $18 on a strong Q2 setup, the asymmetry is exceptional.

• 💸 Max loss is defined: The entire $1.7M premium is at risk if UMC closes at or below $14.00 at June 18 expiration. The buyer accepted that binary — total premium loss versus potentially multi-million dollar upside — which is the defining characteristic of a directional long call.

Translation for regular folks: Imagine you think UMC — a semiconductor foundry that just beat earnings by 48%, authorized its 22nd buyback, and is seeing the first meaningful price hikes in two years — is going to rally another 8% or more over the next 44 days. Instead of buying shares (which requires $14 per share for a much slower payoff), you buy call options that amplify every dollar move above $15.23 into leveraged profit. You pay $1.7M for the right to control 1.5 million UMC shares through June 18. If you're right, the payoff is a multiple of that $1.7M. If you're wrong, you lose the $1.7M. The trader making this call thinks the risk is worth it — and the Z-score of 108 tells us this is far from a routine trade.

---

🎯 Call Mechanics — The Math Behind the $1.7M Bet

📈 Payoff at key UMC price levels at June 18 expiration:

The bull thesis in one sentence: If UMC sustains its post-earnings momentum and the mature-node pricing recovery thesis continues to play out — lifting the stock ~8% above the trade-date spot — this $1.7M call position begins printing profit that scales without limit above $15.23.

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

UMC's 2026 performance has been among the most dramatic recoveries in the semiconductor sector. The ADR collapsed from $10+ in early 2025 to a 52-week low of $6.56 — weighed down by the China-driven mature-node pricing collapse, margin pressure, and global semiconductor inventory correction. Then the turn: a powerful mean-reversion rally off February 2026 lows (~$6.80), accelerating through Q1 into the April 29 earnings print (+6-7% on the day) and continuing into May. The trade-date spot of $14.04 is roughly +107% off the 52-week low — a doubling in under three months.

Key observations from the YTD chart:

• 🚀 Explosive recovery off February lows: The +90% move from $6.80 to $14.04 is not a gradual grind — it is a rerating event driven by pricing-cycle catalyst accumulation (April hikes, Q1 beat, buyback, Singapore ramp).
• 📊 Breaking through prior resistance: The 52-week high was cited at $12.68; UMC at $14.04 is trading above its stated 52-week high, meaning this is a technical breakout into new 12-month territory.
• ⚠️ Extended positioning warning: A +107% move in three months with the stock now above its one-year high means the easy money has been made. The call buyer at $14.04 is purchasing into strength, not at the bottom — they need continued catalyst delivery to push another 8% to breakeven.
• 📈 Momentum confirmation: Higher highs, higher lows since February. The trend structure is intact as of the trade date.

---

Gamma-Based Support & Resistance Analysis

GEX data captures the options market's mechanical anchors as of May 5, 2026, with spot at $14.085:

🔵 Support Levels (Positive Net GEX — Dealer Long Gamma Below Spot):

• $14.00 — Strongest immediate support (total GEX: 2.686B). This is RIGHT AT the long call strike. The enormous positive net GEX at this level means market makers hedging their long gamma positions here will systematically buy UMC stock on any dip toward $14.00. The strike where the call buyer paid $1.23 is simultaneously the most powerful gamma magnet in the entire options surface — a fortuitous alignment. Distance from spot: only 0.60%.

• $13.00 — Secondary support (total GEX: 2.986B). Surprisingly the largest total GEX node in the support stack despite being 7.7% below spot. A break below $14 would likely find this level acting as a significant mechanical floor given dealer hedging activity concentrated here.

• $12.00 — Deeper structural support (total GEX: 2.516B). At 14.8% below spot, this represents a meaningful drawdown that would require a material negative catalyst to reach. The +90% rally from $6.80 built substantial open interest at lower strikes that now serves as layered dealer support.

🟠 Resistance Levels (Call GEX Above Current Price — Dealer Short Gamma):

• $15.00 — Primary overhead resistance (total GEX: 1.089B). This is 6.5% above spot — notably, it is 23 cents below the $15.23 breakeven for the call buyer. Market makers with short call gamma at $15 will hedge by selling UMC stock as price approaches $15, creating a natural friction point. The call buyer must push through $15 to approach their breakeven. Distance from spot: 6.5%.

• $16.00 — Secondary resistance (total GEX: 0.372B). Much lighter than the $15 wall — at 13.6% above spot. Once UMC clears $15.00 with conviction, the path to $16 is structurally less encumbered.

What this means for the call buyer: The $14.00 gamma magnet is actually working in the call buyer's favor as long as UMC stays above $14. Dealers hedging long gamma at $14 will buy every dip to that level, supporting the stock exactly where the call goes from worthless to in-the-money. The primary challenge is cracking the $15.00 resistance ceiling — which is precisely where the breakeven sits. A clean weekly close above $15.00 would represent both a technical breakout and a mechanical shift where dealer hedging behavior flips from headwind to tailwind.

Net GEX Bias: Decisively Bullish — total call GEX of $11.55B versus total put GEX of $1.58B. Market makers are overwhelmingly net long call gamma. This structural positioning provides systematic underlying bid support across the $12-$14 range, reducing the probability of a sustained, uninterrupted decline below the trade's strike.

---

Implied Move Analysis

Options market pricing for the near-term window as of May 5, 2026:

Translation for regular folks: The options market is pricing a 7.94% move by May 15 OPEX — either up to $15.31 or down to $13.06. In raw dollar terms, the market sees $1.13 of potential movement in either direction within the next 10 days alone. This is notable: the upper implied move target of $15.31 is essentially identical to the call buyer's breakeven of $15.23. The options market is saying that a move to breakeven is within the range of what is priced as "normal" near-term volatility for UMC — which is both validating for the bull case and informative about how much uncertainty the market attaches to the current $14 spot.

Critical context for the call buyer:

• The $14 strike call with 44 days to expiration benefits from the elevated implied volatility baked into UMC options — but only if price moves directionally. If UMC stays rangebound near $14, theta decay (time value erosion) will grind the $1.23 premium lower each day.
• The May 7, 2026 monthly sales release is the most immediate catalyst within the 10-day implied move window. A strong April revenue print could be the trigger for a $15+ push that the options market is already pricing as a credible outcome.
• The June 18 expiration sits past the June 7 May-monthly-sales release, the June 24 ex-dividend date ($0.48/ADR), and the June 29 buyback program end — giving the call exposure to all three catalysts in a 44-day window.

---

🎪 Catalysts

✅ Recent Catalysts (Already Happened)

Q1 2026 Earnings Beat — April 29, 2026

UMC delivered its strongest relative earnings surprise in recent memory. Per the official Q1 2026 press release on Businesswire:

• 💰 Revenue: NT$61.04B (+5.5% YoY, −1.2% QoQ vs. NT$61.81B in Q4'25)
• 📊 Net Income: NT$16.17B — +108% YoY / +50% QoQ, boosted by favorable tax benefits
• 🎯 ADR EPS: $0.20 vs. $0.13 consensus — a 48.3% beat
• 🏭 Capacity Utilization: 79% (vs. 69% Q1'25 — a 10 percentage-point YoY improvement), per stocktitan Q1 summary
• 📐 22nm Record Mix: 22/28nm = 34% of revenue; 22nm alone hit a record 14% of revenue
• 💸 ADR reaction: +6-7% on April 29, per Investing.com

The gross margin of 29.2% (vs. 30.7% in Q4'25) was the only softness — but management guided Q2 at "around 30%", indicating the Q1 sequential step-down was transient.

---

22nd Share Buyback Authorization — April 29, 2026

Concurrent with earnings, UMC authorized its 22nd buyback program: up to 50M shares (0.40% of outstanding capital), NT$213B monetary cap, execution window April 30 – June 29, 2026. This buyback provides a structural bid floor for the stock through the exact window the June 18 call expires — management is buying stock with corporate capital while institutional call buyers add 15,000 contracts on the same day.

---

April Mature-Node Price Hikes — Effective Q2 2026

UMC, VIS, PSMC, and Nexchip coordinated price hikes of up to 10% effective April 2026 — the first sustained pricing action after the brutal 2024-2025 China-driven collapse. This is the first evidence of oligopolistic coordination among Taiwan foundries to defend margins. The April hikes have not yet fully flowed through reported ASPs; Q2 will be the first quarter to show the full effect. The call buyer may be positioning ahead of this visible ASP uplift in Q2 guidance.

---

Singapore Fab 12i Phase 3 Volume Production

UMC's $5B Singapore expansion entered volume production in 2026, with Phase 1 targeting 30,000 wpm capacity. Singapore output is outside Chinese regulatory reach, making it strategically attractive for U.S., European, and Japanese IC designers seeking supply-chain diversification away from Taiwan-Strait geopolitical exposure and China-fab regulatory uncertainty.

---

Intel-UMC 12nm Arizona JV — Late 2026 Tape-Outs

Intel and UMC's 12nm joint venture targets first tape-outs at Intel Fabs 12/22/32 in Chandler, Arizona in late 2026, with mass production expected 2027. This is a multi-year partnership that broadens UMC's addressable market into U.S. domestic semiconductor manufacturing — a CHIPS Act-aligned value proposition.

---

🔥 Upcoming Catalysts (What the June 18 Call Is Positioned For)

May 7, 2026 — April Monthly Revenue Release (IMMEDIATE CATALYST)

Per the UMC IR calendar, UMC releases April 2026 revenue on May 7 — two days after this call was purchased and 41 days before June 18 expiration. This is the first read on Q2 2026 momentum and will tell the market whether April's price hike is beginning to flow through shipment values. A strong print (YoY revenue growth above 5-6%) would validate the Q2 guide and likely drive UMC toward the $15.00 resistance level. This is the single most immediate catalyst within the call's lifecycle.

June 7, 2026 — May Monthly Revenue Release

The second monthly data point during the call's 44-day window. By June 7 (11 days before expiration), cumulative April+May revenue will determine whether Q2 is tracking toward the consensus NT$66-67B implied by Q2 guidance. A May print that shows accelerating revenue versus prior year — helped by the full-quarter effect of April price hikes — would be a powerful push toward the $15.23 breakeven.

June 24, 2026 — Ex-Dividend Date ($0.48/ADR)

Per Stock Events dividend tracker, UMC's next ADR dividend ex-date is June 24. While this falls 6 days after the June 18 call expiration, the approaching dividend may attract income-oriented buying in early-to-mid June that provides a positive price underpinning as expiration nears.

June 29, 2026 — Buyback Program End

The NT$213B buyback authorization runs through June 29. Corporate share repurchases provide a systematic mechanical bid during the call's 44-day window. Management executing buybacks at $14 is effectively placing a floor signal — they believe current prices are below intrinsic value, which reinforces the call buyer's thesis.

Late July 2026 — Q2 2026 Earnings

While Q2 earnings fall after the June 18 expiration, the market will begin pricing Q2 expectations into May-June UMC ADR trading. Guidance for Q2 specifically calls for: high-single-digit shipment growth QoQ, low-80% utilization (up from 79% in Q1), ~30% gross margin, and $1.5B full-year capex — all of which, if reiterated or upgraded in monthly data, provide ongoing upward price pressure during the call's active window.

---

🔬 Foundry Fundamentals Deep Dive

Capacity Utilization Trajectory

Utilization is the single most important operational metric for a foundry. UMC's utilization path tells the story of the cycle:

Moving from 69% to 79% to "low 80%" in three consecutive quarters is a textbook foundry recovery trajectory. Foundry economics become meaningfully more favorable above 80% — incremental wafer volume at high utilization drops to the bottom line at near-100% gross margin contribution because fixed costs are already covered. The transition from 79% to low-80%+ utilization in Q2 is a critical inflection. If utilization reaches 85% in Q3 2026, gross margins could expand materially toward 33-35%, which would represent a significant upside catalyst for a stock where the current consensus PT still sits below $10.22 on average.

22nm Mix Shift — The Hidden Value Driver

The progression of 22nm from ~5% of UMC revenue in 2024 to a record 14% in Q1 2026 is a structural ASP uplift story that the mature-node pricing narrative often obscures. 22nm commands meaningfully higher ASPs than 40nm or 65nm — UMC's target mix shift toward 22/28nm as a share of revenue is a durable margin expansion lever that does not depend on fixing the China-oversupply problem. Over 50 customers will complete 22nm tape-outs by end-2026, per UMC management, broadening the 22nm revenue base across display drivers, networking ASICs, and MCU families that require the process.

The China Competition Reality Check

Chinese foundries SMIC and Hua Hong have state-subsidized capacity ramping at 28-90nm nodes with pricing discounts reportedly reaching 30-40% below Taiwan rates. This is the bear case's structural headwind. The April 10% hike coordinated among Taiwan foundries is a direct response to this pressure — an attempt to pass through cost inflation while differentiating on quality, on-time delivery, and geographic supply-chain security.

The nuanced reality: Chinese fabs primarily serve Chinese IC designers. Western, Japanese, and South Korean IC designers are increasingly reluctant to source from Chinese foundries given U.S. export control volatility, IP protection concerns, and end-customer supply-chain compliance requirements. UMC's Singapore Phase 3 and Intel Arizona positioning directly exploits this bifurcation — they are building Western-accessible capacity that Chinese foundries cannot replicate geopolitically.

Hua Hong's preparation of 7nm technology at Huali Microelectronics is a longer-term threat but does not directly compete with UMC's 22/28nm specialty node stronghold in the near term. The mature-node pricing war is real, but the geographic segmentation of the foundry market reduces its bite on UMC's most strategically defensible revenue streams.

ASP Dynamics — Mix vs. Price

Q2 2026 guidance calls for a "low single-digit USD increase" in ASP. Per earnings call commentary, management was explicit: this is mix-driven (more 22/28nm as a percentage of output) rather than price-driven. Pure pricing power has not yet returned. The April hike announcements (up to 10%) remain to be confirmed in actual shipment data — the May 7 and June 7 monthly revenue releases are the empirical tests. If actual ASP per wafer shows improvement above what can be explained by mix alone, that is a materially bullish signal that the pricing environment is healing faster than expected.

Singapore Phase 3 — The Long-Term Structural Moat

UMC's $5B Singapore investment — with Phase 1 ramping toward 30,000 wpm in a jurisdiction outside Chinese regulatory reach — is the cornerstone of the geographic diversification narrative. IC designers evaluating dual-sourcing or primary-sourcing away from Taiwan-based fabs for geopolitical risk management have few alternatives at 22nm specialty scale. UMC Singapore Phase 3 is positioned as that alternative. This is a 2026-2028 revenue story, but the option market pricing over the next 44 days captures the incremental news flow around ramp progress that validates this thesis.

---

🎲 Price Targets & Probabilities

📈 Bull Case (35% probability)

Target: $15.50-$17.00 — Call deep in-the-money at expiration

How we get there:

• ✅ May 7 April revenue release shows 7-10% YoY growth — the first visible evidence of April pricing hikes flowing through shipment values
• ✅ June 7 May monthly revenue confirms the trend — Q2 is tracking above the NT$66-67B consensus
• ✅ Utilization commentary confirms trajectory toward 82-83%, supporting margin expansion narrative
• ✅ Stock clears $15.00 gamma resistance ceiling, triggering a cascade of dealer re-hedging (forced buying as dealers who were short call gamma must delta-hedge with long stock purchases)
• ✅ Analyst community begins closing the gap between their $8-$10 consensus PTs and a stock trading at $14+ — PT upgrade cycle adds institutional sponsorship
• ✅ Buyback execution through June 29 provides mechanical bid support as stock makes new 52-week highs above $15
• 🚀 At $16, the call buyer is sitting on $1.155M profit (+68% return on the $1.7M premium). At $17, profit reaches $2.655M (+156%).

Catalyst required: A strong May 7 April revenue print is the primary trigger. If April revenues come in at NT$22-23B (vs. NT$20.83B in March and NT$20.86B in January), the revenue acceleration narrative becomes too compelling for skeptics to ignore.

Why 35%: The combination of ATM strike, elevated gamma, favorable buyback support, and a specific near-term binary catalyst (May 7) creates better-than-typical odds for a short-dated ATM call versus one purchased on a flat catalyst day.

---

🎯 Base Case (40% probability)

Target: $13.50-$15.00 — Call partially in-the-money or near breakeven at expiry

Most likely scenario:

• ✅ May 7 revenue print is solid but not explosive — YoY growth of 5-6%, consistent with Q1 trajectory
• 📊 Stock tests $15.00 resistance but cannot sustain a clean break — dealers hedge short gamma with systematic selling near $15
• 🔄 UMC consolidates in the $13.50-$15.00 range as the market waits for June 7 May revenue to confirm the Q2 trajectory
• ⚖️ The stock's +90% move from February lows creates profit-taking pressure from earlier longs who are now ITM on shares
• 📈 The call buyer collects partial value ($0.00-$1.23) at expiration depending on where UMC settles
• 💰 At $15.00 (7% rally), the call is $1.00 in-the-money, recovering $1.5M of the $1.7M premium for a modest $200K loss
• 📊 At $14.50 (3.3% rally), the call is $0.50 in-the-money — $750K value recovered on $1.7M invested

For the call buyer: The base case involves a partial recovery of premium rather than a full loss, which reflects the ATM strike's favorable positioning — even a moderate rally captures meaningful value.

Why 40%: This is the "slow-burn" scenario for a stock that has already made a dramatic move. The fundamental thesis is valid but the stock needs a near-term catalyst to punch through $15 resistance decisively.

---

📉 Bear Case (25% probability)

Target: $11.50-$13.50 — Call expires worthless, full $1.7M loss

What could go wrong:

• 😰 May 7 April revenue disappoints — flat to modestly negative YoY, suggesting the April price hikes are not yet translating or that volume is weaker than utilization guidance implied
• ⚠️ China oversupply intensifies — SMIC or Hua Hong announce aggressive capacity expansion at 28nm, forcing another pricing capitulation that reverses the April hike momentum
• 💸 Profit-taking from the +90% February-to-May rally accelerates — early longs selling $6.80-purchased shares into $14 creates structural distribution pressure
• 📉 Analyst community triggers a downgrade wave — the current consensus PT of $8.17-$10.22 versus a $14 spot is a fundamental overhang that could attract sell-side recalibration if monthly data is uninspiring
• 🔴 Executive insider selling from March 2026 (CFO trimmed 600K shares) weighs on sentiment — management knew Q1 was strong and still reduced personal holdings
• ❗ Broader ADR sell-off in Taiwan-listed names if geopolitical risk premium spikes
• 📊 Stock falls back below $14 gamma magnet level, loses dealer support, probes $13.00 secondary support

Support levels to watch:

• 🛡️ $14.00 — Strongest immediate support (GEX: 2.686B). This is exactly the call strike. A breach below $14 signals both options-market and technical breakdown — the call buyer's delta goes below 0.50 and the position accelerates in decay.
• 🛡️ $13.00 — Secondary support (GEX: 2.986B — heaviest total node). A 7.7% pullback would reach here. Significant dealer buying expected, making a sustained move below $13 difficult without a decisive fundamental negative.
• 🛡️ $12.00 — Structural floor (GEX: 2.516B). A 14.8% decline would test this level; most scenarios where UMC approaches $12 involve a broader semiconductor sector de-rating event, not UMC-specific deterioration.

Bear case probability: 25% — The combination of active buyback, ATM gamma support at $14, and the sequential catalyst calendar (May 7, June 7 data, dividend ex-date, buyback end) creates enough near-term positive pressure to make a full premium wipeout the minority scenario rather than the base case.

---

💡 Trading Ideas

🛡️ Conservative: Sell Cash-Secured Puts at the $13 Gamma Floor

Strategy: Sell cash-secured UMC put options at the $13 strike (June 18 or May 15 expiration) — collecting premium while expressing a willingness to own UMC at a 7.7% discount to current spot.

Why this works:

• 📊 The gamma data identifies $13.00 as UMC's second-strongest support level (total GEX: 2.986B — actually the heaviest total node in the GEX map). Market makers with long gamma at $13 will systematically buy dips toward this level, making a sustained breach unlikely without a major exogenous shock.
• 💰 Selling the June 18, 2026 $13 put collects premium in an environment where UMC options implied volatility is elevated — the May 15 implied move of ±7.94% means put premiums are pricing meaningful downside risk. You get paid to promise to buy UMC at a level where gamma dynamics provide strong mechanical support.
• 🎯 The active buyback (through June 29) means corporate capital is also supporting shares near current levels — you are aligning your short put position with management's own buying program, which is a textbook favorable setup.
• ⏰ If using May 15 expiration (10 days), the probability of a 7.7% decline to the $13 put strike in 10 days is relatively low given the buyback bid and gamma floor. Even in the "bear base case" — a stock that fails to break out above $15 but holds the $14 range — the $13 put expires worthless.
• 🔄 If the put is assigned (stock falls to or below $13 at expiration), you acquire UMC at an effective cost of $13 minus the premium collected — a level where the buyback authorization provides strong institutional demand.

Approximate target premium: $0.30-$0.60 per share for the May 15 $13 puts; $0.60-$1.00 per share for the June 18 $13 puts (exact pricing depends on current IV and bid-ask spread)

Breakeven: Strike minus premium collected. If you collect $0.70, your effective cost basis on assignment is $12.30 — a 12.4% discount to trade-date spot.

Risk level: Low to moderate (requires willingness and capital to own UMC at $13 if assigned) | Skill level: Intermediate

Strategy name: "The Buyback Synergy Put" — your short put position and management's buyback program are both bidding for UMC shares at a discount to spot.

---

⚖️ Balanced: Bull Call Spread — Define the Risk, Narrow the Breakeven

Strategy: Buy the June 18, 2026 $14 call (the whale's strike), sell the June 18, 2026 $15 call — creating a $1-wide bull call spread that reduces breakeven from $15.23 (naked long call) to approximately $14.55-$14.70 while capping max profit at $15.

Why this works:

• 🎯 Lower breakeven. If you pay $1.23 for the $14 call and collect $0.55-$0.65 for the $15 call, your net debit drops to approximately $0.58-$0.68 per share. Your new breakeven becomes $14.58-$14.68 — less than 5% above current spot, versus the naked call's 8.5%. That is a dramatically more achievable target.
• 💸 Defined max risk. Your maximum loss is the net debit — no matter what UMC does to the downside. If UMC falls to $10, the spread still loses only the net debit, not the full $1.23 premium of the long leg alone (which would also lose less due to the short leg offset, but the spread guarantees a defined ceiling on losses).
• 📊 Captures the first resistance level as the target. The $15.00 strike corresponds directly to the primary gamma resistance ceiling identified in the GEX analysis. By selling the $15 call, you are monetizing the value of a move to the resistance wall rather than betting on a breach through it. If UMC reaches exactly $15.00, your spread is nearly at maximum value.
• 🔄 Aligns with the May 15 implied move. The options market prices UMC reaching $15.31 as the upper end of near-term normal volatility. Selling the $15 call at that resistance zone captures the maximum value the market is currently assigning to the bull scenario.
• ⚖️ Trade-off: Max profit is capped at approximately ($15 − $14 − net debit). If UMC blasts through $15 toward $17, the spread stops participating above $15 while the naked long call continues to accrue value. You are giving up the uncapped upside that made the whale's trade so compelling — but at significantly lower capital at risk and a breakeven 36% closer to current spot.

Approximate structure:

• Buy June 18 $14 call: Pay ~$1.23
• Sell June 18 $15 call: Collect ~$0.55-$0.65
• Net debit: ~$0.58-$0.68 per share
• Breakeven: ~$14.58-$14.68 (3.8-4.6% rally needed)
• Max loss: Net debit × 100 × number of spreads
• Max gain: ($1.00 − net debit) × 100 × number of spreads (approximately $0.32-$0.42 per share, or 47-72% return on capital at risk)

Risk level: Moderate — you can still lose 100% of net debit | Skill level: Intermediate | Position size: Allocate no more than 2-3% of portfolio per trade

---

🚀 Aggressive: Ride the Whale's Exact Structure — Long $14 Call, No Hedge

Strategy: Mirror the institutional trade exactly — buy the June 18, 2026 $14 calls at-the-money with no spread or hedge — accepting full premium loss as the defined downside in exchange for unlimited upside above $15.23.

Why the whale might be right:

• 🐋 A Z-score of 108.45 with 25x vol/OI means this is not noise. When 15,000 contracts land in a single print at 13:59:42 against 592 OI, it reflects institutional conviction, not retail speculation. The buyer at the other end of this trade has almost certainly read the Q1 earnings transcript, modeled the Q2 utilization guide, and priced in the May 7 catalyst sequence.
• 🎯 ATM positioning is intentional. The buyer chose the $14 strike when spot was $14.04 — not the $13 (in-the-money), not the $15 (out-of-the-money). ATM maximizes gamma exposure: every $1 move in UMC stock translates to approximately $0.50 in option value change at the point of purchase. The buyer wants maximum price sensitivity, not margin-of-safety premium.
• 📅 44-day window captures all three near-term catalysts: May 7 April revenue, June 7 May revenue, and the full duration of the buyback program (through June 29, 11 days after expiration). Three binary catalysts in a 44-day window for a stock with demonstrated fundamental momentum is precisely when short-dated ATM calls make structural sense.
• 💡 The options market agrees the target is reachable: The May 15 implied move puts $15.31 as the upper range of normal near-term volatility. The call buyer's $15.23 breakeven is almost exactly where the options market prices the near-term bull scenario. This is not a wildly optimistic bet — it is a bet calibrated precisely to what the market is already pricing as a likely outcome.
• 🏭 The fundamental cycle is accelerating, not decelerating. Utilization going from 69% → 79% → "low 80%" over three quarters, 22nm hitting a record 14% mix, Singapore Phase 3 volume ramping, Intel Arizona tape-outs approaching — these are compounding positives, not one-offs.

The uncomfortable truth about risk:

• ⚠️ $1.7M — or a proportional retail equivalent — evaporates completely if UMC is at or below $14.00 at June 18 close. This is a binary outcome: either the fundamental thesis delivers or the premium goes to zero. There is no partial win below $14.00.
• 💸 Theta will grind you. At ATM with 44 days, theta decay is near its peak rate. If UMC is still trading at $14.00 on June 10 (8 days before expiration), the remaining time value will be minimal — you would need to decide whether to close for a small residual value or ride to expiration.
• 📉 The stock has already rallied 107% off February lows. Buying calls 8.5% above a stock that has already doubled is a high bar. The easy consensus trade for UMC bulls who bought in February is already a multi-bagger. New money at $14 needs continued catalyst delivery to justify the premium paid.
• ⚠️ Insider selling is a yellow flag. CFO Chitung Liu trimmed 600,000 shares in March 2026 — weeks before the Q1 beat — reducing his holdings by ~13%, per stocktitan SEC filing summary. Insider selling before a positive earnings print, while not dispositive, warrants acknowledgment.

Retail sizing guidance:

• Limit to 1-2% of total portfolio per options position
• If purchasing multiple contracts, spread entries over 2-3 days rather than entering the full size at once
• Set a hard exit rule at 50% premium loss (if the call drops from $1.23 to $0.60, consider closing to preserve capital)
• Critical: Do not add to a losing position. If UMC falls below $13.50 and the May 7 revenue miss is the cause, that is a signal to respect — not an opportunity to average down on options with limited remaining time value.
• Watch May 7 obsessively. If April revenues disappoint, consider closing the position before theta accelerates into late May.

Risk level: HIGH — full premium loss is the baseline adverse scenario | Skill level: Advanced | Only suitable for capital that can be forfeit entirely

---

⚠️ Risk Factors

The bear traps specific to this trade:

• 🇨🇳 China mature-node oversupply remains structurally unresolved. Chinese fabs are projected to capture ~50% of new global mature-node capacity additions by 2027. The April 10% price hikes are a coordinated oligopolistic response, but Chinese foundries offering 30-40% discounts with state subsidy backing will cap how much Western foundries can raise prices before customers begin qualifying Chinese fabs for non-geopolitically-sensitive designs. If the April hike proves to be a failed attempt — if IC designers balk and route volume to lower-priced alternatives — Q2 revenue could miss the guidance implied by that hike.

• 📊 ASP improvement is mix-driven, not price-driven. Management was explicit on the Q1 call: Q2 ASP improvement reflects more 22/28nm versus older nodes, not a pricing environment recovery, per earnings call transcript at Investing.com. If you strip out the mix effect, underlying ASPs at legacy nodes are flat to down. The April hike validation will not be visible until June 7 at the earliest.

• 📉 Stock at $14 is already well above analyst consensus PTs. The average analyst price target is $8.17-$10.22 against a $14 spot. This is a significant fundamental disconnect — not because the stock is wrong, but because analysts are lagging a rapid rerate. As analysts update models post-Q1, PT upgrades could provide a tailwind — but if Q2 data disappoints and triggers downgrades FROM $8-$10 PTs on a $14 stock, the downward pressure could be amplified.

• 💸 Q1 net income was tax-aided, not purely operational. The 108% YoY net income surge was partly driven by tax benefits — the underlying operating performance, while genuinely strong (utilization 79%, 22nm record), was less spectacular than the headline net income number implies. Gross margin already stepped back 150bps QoQ from Q4 to Q1.

• 🏢 Executive insider selling. CFO and multiple VPs reduced personal holdings in March 2026 just weeks before the Q1 print. The CFO reduced his personal stake by ~13% ahead of a quarter that saw the ADR spike 6-7%. While insiders sell for many reasons and the Q1 beat suggests the sales were opportunistic rather than distress-related, the pattern warrants monitoring for continued insider selling disclosures.

• ⏰ 44 days is a short fuse for an 8.5% rally. The implied breakeven of $15.23 requires UMC to move 8.5% from $14.04 in 44 calendar days. If the May 7 revenue print lands flat and the next data point is June 7, there are only 11 days between the June 7 release and the June 18 expiration. A weak May 7 print could effectively condemn the call to near-expiration with insufficient time value for recovery.

• 🌐 Taiwan-Strait geopolitical risk premium is structural for ADRs. UMC is a Taiwan-listed ADR with the bulk of its manufacturing in Taiwan. Any escalation in cross-strait tensions — even rhetorical — creates a multiple compression event for all Taiwan semiconductor names. This risk does not correlate with UMC's fundamentals and can materialize without warning.

• 🔄 Tariff policy and the AI chip export regime. The January 2026 Commerce Department final rule and the pending AI Overwatch Act create an environment where semiconductor supply chains are subject to rapid regulatory changes. For UMC specifically, the Intel 12nm Arizona partnership is partly motivated by CHIPS Act alignment — any policy rollback or reinterpretation could reduce the strategic premium assigned to that partnership.

---

🎯 The Bottom Line

Real talk: A single institutional buyer committed $1.7M in premium to open 15,000 contracts of UMC June 18 $14 calls at 13:59:42 on May 5, 2026 — hitting at-the-money with spot at $14.04, printing a Z-score of 108.45 against only 592 contracts of prior open interest. This is a concentrated, standalone directional bet on the Taiwan foundry recovery thesis with 44 days to run. The structure — naked long call, no spread — tells you about the buyer's conviction: they want uncapped upside, not defined-risk asymmetry. They paid the full $1.23 premium per share because they believe the next 44 days' catalyst sequence (May 7 revenue, June 7 revenue, active buyback, Singapore Phase 3 ramp, Intel 12nm timeline progress) will push UMC above the $15.23 breakeven and deliver outsized returns on $1.7M at risk.

What the whale is telling us:

• 🎯 They believe the Q1 beat is the beginning of a cycle, not a one-off. A 48% EPS beat driven by a 10pp YoY utilization improvement and record 22nm mix does not happen in a company with a deteriorating business. The buyer is front-running the Q2 narrative.
• 🏭 The Singapore + Intel Arizona combination is an underappreciated moat. UMC is the only mature-node foundry with significant capacity outside Taiwan, outside China, and with a U.S. domestic manufacturing footprint (via the Arizona JV). The premium assigned to supply-chain resilience by Western IC designers is growing — and UMC is positioned to capture it.
• 📅 The buyback is a floor bid signal. Management authorizing NT$213B in buybacks through June 29, effective April 30, tells the call buyer that corporate capital is competing in the same market as their $1.7M call premium. You do not spend NT$213B buying your own stock if you think it is overvalued.
• 🔥 ATM choice is deliberate. At $14.00 with spot at $14.04, the buyer chose the highest-gamma, highest-theta, highest-price-sensitivity option on the board. This is not a conservative "sell some theta" structure. This is a bet on near-term directional momentum with maximum leverage to price movement.

If you own UMC stock:

• ✅ The institutional long call is confirmation of directional conviction — hold through May 7 and June 7 data releases
• 📊 $14.00 is both the strongest gamma support and the call strike — that level becomes a hard near-term floor with market makers, corporate buyback, and institutional call buyers all providing buying interest
• 📅 Watch May 7 revenue release obsessively — it is the first confirming or disconfirming data point within the call's 44-day window
• ⚠️ If June 7 May revenue is weak and you are holding shares above $13, consider whether the fundamental momentum thesis is intact

If you're watching from the sidelines:

• 🔍 The May 7 April revenue release is the first binary event. A strong print (YoY growth above 6%) could push UMC through the $15.00 resistance ceiling — watch for that level as the first technical confirmation
• 📈 The gamma picture shows $14.00 as an exceptionally well-supported floor and $15.00 as the primary resistance. The price action in the next 10 days likely resolves in the $13.50-$15.31 range implied by the options market
• 🎯 If UMC breaks above $15.00 on strong May 7 volume, that is the signal the bull case is materializing — not a reason to chase, but a reason to size into the next structure at more favorable entry

If you are bearish on UMC:

• ⚠️ Fighting a Z-score-108 institutional call buyer in a stock with an active corporate buyback is a difficult trade. The burden of proof is on the bear to explain what specific catalyst overcomes the mechanical bid from three sources: market maker gamma hedging at $14, NT$213B in corporate repurchases, and a freshly opened $1.7M institutional call position.
• 📊 The bear case exists — China oversupply, lagging analyst PTs, insider selling, mix-driven (not price-driven) ASP improvement — but executing a short or long put position against the near-term catalyst stack requires high conviction and precise timing.
• 🛡️ If you must hedge, the first clean technical and gamma-supported breakdown level is $13.00 — a 7.7% decline that would break the $14 support. A sustained close below $13 on volume, particularly on a weak revenue release, would be the structural break signal.

Mark your calendar — Key dates:

• 📅 May 7, 2026 — April 2026 monthly revenue release: first read on Q2 momentum and price hike flow-through per UMC IR calendar
• 📅 May 15, 2026 — Monthly OPEX; options market implies ±7.94% move (±$1.13) from $14.19 reference; upper range $15.31
• 📅 June 7, 2026 — May 2026 monthly revenue: second data point confirming or denying Q2 trajectory
• 📅 June 18, 2026 — Call expiration; final settlement date
• 📅 June 24, 2026 — Ex-dividend date ($0.48/ADR); per Stock Events
• 📅 June 29, 2026 — Buyback program end; NT$213B authorization closes
• 📅 Late July 2026 — Q2 2026 earnings; consensus implies NT$66-67B revenue, ~30% gross margin, low-80% utilization; also June monthly sales (July 7)

Final verdict: UMC delivered a 48% EPS beat driven by a 10 percentage-point YoY utilization improvement, a record 22nm revenue mix, an active NT$213B buyback, and the first coordinated mature-node price hikes up to 10% in over a year. The whale buying $1.7M in June $14 calls is expressing a specific view: the cycle is turning, the next 44 days will confirm it with monthly revenue data, and the $14.00 ATM strike is the optimal point of gamma leverage to capture that confirmation. Whether they are right depends almost entirely on May 7. If April revenues print strong, UMC above $15 becomes the base case, not the bull case. If they miss, the $1.7M evaporates — but the fundamental thesis remains intact for a longer-duration bet.

Be disciplined. The catalyst calendar is dense. The gamma floor at $14 is strong. And the whale just bet $1.7 million that Taiwan's foundry recovery is real — sized with maximum conviction in 44 days.

---

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice, a solicitation, or a recommendation to buy or sell any security. Past performance of unusual options flow does not guarantee future results. The long call position described involves a maximum loss of 100% of the premium paid ($1.7M at the institutional level shown). Long call positions decay in value as expiration approaches if the underlying does not move above the strike plus premium paid. The breakeven of $15.23 requires an approximately 8.5% rally from the $14.04 trade-date spot price within 44 days. Institutional trades may reflect hedging, index rebalancing, portfolio optimization, or other strategic purposes not visible to outside observers. UMC ADRs are subject to currency risk (TWD/USD), Taiwan-Strait geopolitical risk, and regulatory risk across U.S.-China semiconductor policy. Options pricing is dynamic and the specific strikes, premiums, and probabilities discussed reflect conditions as of May 5, 2026, at the time of the trade. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

---

About United Microelectronics Corporation: United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) is Taiwan's second-largest pure-play semiconductor foundry and one of the world's leading manufacturers of specialty and mature-node integrated circuits. Founded in 1980 and headquartered in Hsinchu, Taiwan, UMC operates 12 fabs across Taiwan, Singapore, China (Xiamen, Suzhou), and Japan (Mie), delivering 22nm/28nm specialty, 40nm, and 65nm process technologies across display drivers, image sensors, MCUs, RF/IoT, power-management, and automotive IC applications. Market capitalization approximately $24.4B-$30.9B. Industry classification: Semiconductor Manufacturing / Pure-Play Foundry Services.